Pharma major Wockhardt, which made a successful turnaround, plans to exit its corporate debt restructuring (CDR) programme by this financial year. The company, which approached the CDR cell to initiate the exit process, plans a pre-payment to clear its debts, said Habil Khorakiwala, chairman, Wockhardt, on the sidelines of the company’s annual general meeting.